Transcription-based drug repurposing for COVID-19

We have utilised the transcriptional response of lung epithelial cells following infection by the original Severe Acute Respiratory Syndrome coronavirus (SARS) to identify repurposable drugs for COVID-19. Drugs best able to recapitulate the infection profile are highly enriched for antiviral activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Killick, Richard, Ballard, Clive, Doherty, Patrick, Williams, Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518800/
https://www.ncbi.nlm.nih.gov/pubmed/32987033
http://dx.doi.org/10.1016/j.virusres.2020.198176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518800/
https://www.ncbi.nlm.nih.gov/pubmed/32987033
http://dx.doi.org/10.1016/j.virusres.2020.198176

Ejemplares similares